Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue

https://doi.org/10.1016/0014-2999(90)94164-SGet rights and content

Abstract

Endothelin (ET)-like immunoreactivity (-LI) was detected in the human cardiopulmonary system, with the highest levels being found in the left anterior descending coronary artery, followed by the lung, right atrium, pulmonary artery, bronchus, pulmonary vein and left ventricle. Chromatographic characterization showed that the ET-LI in the lung and left ventricle corresponded to synthetic ET-1. Specific, high-affinity binding sites for ET-1, with an extremely slow dissociation rate, were found in the lung, right atrium and left ventricle. Displacement studies revealed a rank order of potency of ET-1 > ET-2 and sarafotoxin 6b > ET-3 and big ET-1. Scatchard analysis indicated a single receptor population in the lung (KD 1.53 × 10−10 M) and left ventricle (KD 3.0 × 10−11 M). In functional experiments, ET-1 evoked concentration-dependent, long-lasting vasoconstriction of a higher potency than that evoked by ET-2 and ET-3 in epicardial coronary arteries as well as in pulmonary arteries. ET-1 and ET-2 also showed bronchoconstrictor activity at considerably lower concentrations (threshold 10−11 M) of ET-1 than those needed to cause vasoconstriction (10−9 M). ET-LI, mainly consisting of ET-1, occurs in human cardiopulmonary tissue. Specific, high-affinity sites with irreversible binding for ET-1 are found in both the heart and lung. ET-1 is more potent than ET-2 or ET-3 in displacing ET-1 binding and in causing vasoconstriction and bronchoconstriction. Thus, in the human heart and lung, ET-1 seems to be the most abundant and biologically active of the endothelin peptides.

References (37)

  • Y. Masuda et al.

    Two different forms of endothelin receptors in rat lung

    FEBS Lett.

    (1989)
  • H. Matsumoto et al.

    Abundance of endothelin-3 in rat intestine, pituitary gland and brain

    Biochem. Biophys. Res. Commun.

    (1989)
  • A. Nomura et al.

    Endothelin and bronchial asthma

    Lancet

    (1989)
  • R.F. Power et al.

    Autoradiographic localisation of endothelin binding sites in human and porcine coronary arteries

    European J. Pharmacol.

    (1989)
  • K. Salminen et al.

    Modulation of coronary tone in acute myocardial infarction by endothelin

    Lancet

    (1989)
  • C. Takasaki et al.

    Sarafoloxins 6b: several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart

    Toxin

    (1988)
  • Y. Uchida et al.

    Endothelin, a novel vasoconstrictor peptide. as potent bronchoconstrictor

    European J. Pharmacol.

    (1988)
  • G. De Nucci et al.

    Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothclium-derived relaxing factor

  • Cited by (0)

    View full text